Continuous glucose monitors, or CGMs, have transformed diabetes management by allowing people to track their glucose levels in real time without the repeated finger pricks of traditional testing.
For many, however, the biggest question is financial: does insurance cover continuous glucose monitors? The short answer is yes, but the extent of that coverage depends on your insurance plan, your medical diagnosis, and even the brand of CGM you choose. This guide explores how insurance coverage for CGMs works, what requirements must be met, and how to make sure you get the most from your policy.
Before diving into coverage, it helps to understand what CGMs actually do and why they have become so essential in diabetes care. A CGM is a small device that tracks glucose levels throughout the day and night. It consists of three key parts: a tiny sensor inserted under the skin, a transmitter that sends data, and a receiver or smartphone app that displays your glucose trends.
The biggest advantage of CGMs is that they give you continuous, real-time glucose readings instead of single test results. You can see how your blood sugar changes after meals, exercise, stress, or sleep, allowing for better insulin adjustments and lifestyle decisions.
CGMs have become a critical tool for people with both Type 1 and Type 2 diabetes, especially those using insulin therapy. They provide insight that can prevent dangerous lows (hypoglycemia) or highs (hyperglycemia) before they become emergencies. Because of this, insurance companies increasingly view CGMs as medically necessary rather than luxury devices.
Insurance coverage for CGMs has evolved in recent years. Initially, only people with Type 1 diabetes could qualify for reimbursement. Today, many insurance providers, including Medicare, Medicaid, and private insurers, offer partial or full coverage for both Type 1 and insulin-dependent Type 2 diabetes patients.
Insurance generally covers CGMs if they are prescribed as medically necessary and used under a doctor’s supervision. However, every policy has its nuances, and it’s important to understand a few common patterns:
Most major private insurers, like Blue Cross Blue Shield, Cigna, and UnitedHealthcare, include CGMs in their diabetes management coverage. However, approval often depends on meeting certain conditions. You may need:
Some plans require prior authorization, meaning your healthcare provider must submit paperwork proving medical necessity before the device is approved. This process can feel tedious but usually speeds up once your doctor provides detailed records.
Medicare began covering CGMs in 2017, but with strict criteria. As of 2023, coverage has expanded significantly. Beneficiaries must:
Medicare typically covers 80% of the cost after you meet your deductible, while supplemental insurance may handle the rest. Devices like Dexcom G7 and FreeStyle Libre are common under Medicare coverage.
Medicaid policies vary by state, so coverage can differ widely. Some states fully cover CGMs for eligible patients, while others limit coverage to children or people with specific medical needs. For example, California and New York have broad coverage policies, while smaller states may require case-by-case approval. The best approach is to contact your state Medicaid office or your healthcare provider’s billing department to confirm what’s available.
Even when CGMs are technically covered, approval is not automatic. Insurers often apply medical necessity guidelines to determine who qualifies. Understanding these factors can help you avoid delays or denials in your claim.
Your healthcare provider must document why a CGM is medically necessary. For instance, frequent hypoglycemia, fluctuating glucose levels, or use of multiple daily insulin injections often qualify as valid reasons. Insurance companies use these records to assess whether the device improves your diabetes management.
If you test your glucose several times a day, insurers may view a CGM as a way to reduce test strip costs over time. Most policies require proof that you’ve been monitoring your glucose consistently using traditional methods.
Using insulin especially in multiple daily doses or through a pump typically makes you eligible for CGM coverage. Those not on insulin may still qualify if they experience frequent glucose fluctuations, but approval might take longer.
Some insurers have preferred brands or suppliers. For example, one plan might cover FreeStyle Libre but not Eversense. Always check the list of approved CGMs and confirm whether the transmitter, sensors, and supplies are all included in coverage.
Without insurance, a CGM can be expensive. The upfront cost includes the receiver or reader (ranging from $70 to $350), sensors that must be replaced every 7 to 14 days, and transmitters that last several months.
A year’s worth of supplies can cost anywhere between $1,000 and $3,000, depending on the brand and usage frequency. Dexcom systems tend to be on the higher end of this range, while FreeStyle Libre offers more budget-friendly options.
This cost difference is one of the main reasons patients explore insurance coverage early on. Even partial reimbursement can reduce expenses significantly, especially since glucose management is a lifelong need.
The approval process can feel confusing at first, but following clear steps can make it smoother. Here’s how to navigate it effectively.
Start by talking with your endocrinologist or primary care provider about your blood sugar patterns. If you experience frequent highs or lows or find fingerstick testing difficult, your doctor can determine whether a CGM is appropriate. They will document your glucose logs and insulin use, which are vital for authorization.
Call your insurance provider’s member services line or check their website for “durable medical equipment” or “diabetes management devices.” Ask:
Take notes during the call and request written confirmation. This helps if you encounter issues later.
Your doctor’s office usually handles prior authorization. They’ll send your medical records, insulin prescriptions, and glucose logs to your insurance provider. Approval can take a few days to several weeks, depending on the insurer.
Once approved, you may need to order your CGM from a specific supplier or pharmacy network. For example, some insurers partner with companies like Edgepark or CCS Medical. Others allow you to purchase through major pharmacies such as CVS or Walgreens.
If you buy a CGM out of pocket due to urgent need, keep your receipts and submit a reimbursement claim with your insurer. Include a copy of your doctor’s prescription and proof of medical necessity.
Even with documentation, some claims get denied. Knowing why can help you respond effectively.
Common reasons for denial include:
If you receive a denial letter, don’t panic. You can appeal by submitting additional documentation from your healthcare provider, including glucose logs and a detailed letter explaining why the CGM is essential for your diabetes management. Many people win appeals when they present solid medical evidence and persistence.
Coverage Under Health Savings Accounts and Flexible Spending Accounts
Even if your insurance plan has high deductibles or limited coverage, you can still offset costs using a Health Savings Account (HSA) or Flexible Spending Account (FSA).
Both allow you to pay for qualified medical expenses, including CGMs and replacement sensors, using pre-tax dollars. This effectively reduces your out-of-pocket costs by your tax rate. Always keep receipts and check your plan’s rules for reimbursement.
Comparing Insurance Coverage by CGM Brand
Here’s a brief comparison showing how major CGM brands typically fit into insurance policies in the United States:
| Brand | Average Coverage Rate | Medicare Approved | Typical Replacement Cycle | Coverage Notes |
| Dexcom G7 | Widely covered by private and Medicare plans | Yes | 10 days per sensor | Often preferred by insurers for accuracy |
| FreeStyle Libre 3 | High coverage, especially through pharmacies | Yes | 14 days per sensor | Lower cost makes approval faster |
| Medtronic Guardian Connect | Moderate coverage | Limited | 7 days per sensor | Usually tied to insulin pump users |
| Eversense E3 (implantable) | Variable coverage | No (as of 2025) | 180 days per sensor | Requires in-clinic insertion, so prior approval essential |
Insurers tend to prefer CGM systems that lower hospitalizations and emergency visits, which makes documenting your health outcomes especially important.
Even with insurance coverage, you might still face co-pays or coinsurance. For example:
Your healthcare provider’s billing team can estimate your monthly or annual expenses once your policy is verified.
If costs remain high, manufacturers often provide savings programs. For instance, Abbott’s FreeStyle Libre offers discount cards, and Dexcom runs patient assistance programs for those with limited income. These can combine with insurance benefits for further relief.
Insurance coverage for CGMs is expanding rapidly as evidence grows of their benefits in preventing hospitalizations, improving glucose control, and enhancing quality of life. The American Diabetes Association (ADA) has pushed for broader inclusion, and newer Medicare rules have made CGMs more accessible to people using any form of insulin.
The trend suggests that CGMs will soon become standard coverage for most diabetes patients, not just those on intensive insulin regimens. As more devices become affordable and FDA-approved for over-the-counter use, insurance policies will likely continue evolving to match real-world needs.
Getting your CGM covered is only part of the story knowing how to maintain coverage and minimize costs matters just as much. Here are a few useful tips:
These steps can save you hundreds of dollars annually and prevent frustrating claim rejections.
Now that you understand how insurance coverage works, it’s worth exploring the main types of continuous glucose monitors available today. CGMs fall into three general categories: wearable sensors, implantable sensors, and integrated pump systems. Wearable sensors, like Dexcom and FreeStyle Libre, are the most popular because they’re small, accurate, and sync seamlessly with smartphones. Implantable systems such as Eversense last longer up to six months but require minor procedures for insertion. Integrated pump systems, like Medtronic Guardian, pair with insulin pumps for automatic insulin delivery based on glucose readings.
Choosing the right CGM depends on your lifestyle, comfort level, and insurance coverage. If affordability and minimal maintenance matter most, pharmacy-dispensed wearables might be ideal. For those seeking long-term monitoring without frequent sensor changes, implantable systems could be worth the higher initial cost. Always balance your health needs, insurance policy, and personal preferences before making the final decision. With the right device and proper coverage, managing diabetes can become simpler, safer, and more efficient than ever before.
